Technology & Software Global On demand · 24-48h

Global Mobile Blood Collection Service Market Strategic Research Report

Global Mobile Blood Collection Service Market Strategic Rese…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Mobile Blood Collection Service Market
$5982025
4.6%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Specimen Collection, Specimen Processing, Specimen Transport, Others

By Application: Cancer, Infectious Disease, Vaccine Clinical Trials, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: NeoGenomics Laboratories, Viracor-lBT Laboratories, Angel's on Wheels Mobile Phlebotomy, Sonora Quest Laboratories, TravaLab LLC, Ultimate Wellness Providers, Mobile Phlebotomy Services, Pinnacle Mobile Phlebotomy, VeniExpress, Progressive Phlebotomy Services

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 85 pages
Market size 2025
$598
Million USD
Forecast CAGR
4.6%
2025-2032
Forecast 2032
$819.3
Projected
Regiones
5
Asia Pacific · Latin America · MEA · Europe · North America

Vista general

Scope of the Report

The global Mobile Blood Collection Service market size is predicted to grow from US$ 598 million in 2025 to US$ 813 million in 2032; it is expected to grow at a CAGR of 4.6% from 2026 to 2032.

During the COVID-19 outbreak, the demand for mobile blood collection services has increased significantly as it is a safer and more convenient process considering the current conditions and circumstances.

Most people will get routine blood tests, but because of the coronavirus, many people are reluctant to go to a hospital or clinic because of the risk of exposure to or potential infection with the virus. Due to widespread concerns and restrictions, mobile blood collection services are becoming increasingly popular.

Rising prevalence of cancer and infectious diseases, increasing demand for home point-of-care testing among the masses, and development of innovative home care technologies are the key factors driving the growth of mobile blood collection services market revenue.

This report presents a comprehensive overview of the global Mobile Blood Collection Service market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Specimen Collection
  • Specimen Processing
  • Specimen Transport
  • Others

Segment by Application

  • Cancer
  • Infectious Disease
  • Vaccine Clinical Trials
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Mobile Blood Collection Service market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Cancer, Infectious Disease, Vaccine Clinical Trials evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Mobile Blood Collection Service Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 4.6%
Regional growth momentum
Market share by segment
Key metrics
Base value
$598
2025
Forecast
$819.3
2032
CAGR
4.6%
2025–2032
Regiones
5
global
Key companies
NeoGenomics LaboratoriesViracor-lBT LaboratoriesAngel's on Wheels Mobile PhlebotomySonora Quest LaboratoriesTravaLab LLCUltimate Wellness ProvidersMobile Phlebotomy ServicesPinnacle Mobile Phlebotomy
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Specimen CollectionSpecimen ProcessingSpecimen TransportOthers
By Application
CancerInfectious DiseaseVaccine Clinical TrialsOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Specimen Collection
  • 3.1.3 Specimen Processing
  • 3.1.4 Specimen Transport
  • 3.1.5 Others
  • 3.1.6 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Cancer
  • 4.1.3 Infectious Disease
  • 4.1.4 Vaccine Clinical Trials
  • 4.1.5 Others
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 NeoGenomics Laboratories
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Viracor-lBT Laboratories
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Angel's on Wheels Mobile Phlebotomy
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Sonora Quest Laboratories
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 TravaLab LLC
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Ultimate Wellness Providers
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Mobile Phlebotomy Services
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Pinnacle Mobile Phlebotomy
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 VeniExpress
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Progressive Phlebotomy Services
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Mobile Blood Collection Service market?
The global Mobile Blood Collection Service market is estimated at US$ 598 million in 2025 (base year) and is projected to reach US$ 813 million by 2032.
How fast is the Mobile Blood Collection Service market expected to grow?
The market is expected to grow at a CAGR of 4.6% from 2026 to 2032, expanding from US$ 598 million in 2025 to US$ 813 million in 2032, roughly 1.4 times its base-year value.
What does the Mobile Blood Collection Service market cover?
During the COVID-19 outbreak, the demand for mobile blood collection services has increased significantly as it is a safer and more convenient process considering the current conditions and circumstances.
How is the Mobile Blood Collection Service market segmented by type?
By type, the market is segmented into Specimen Collection, Specimen Processing, Specimen Transport and Others.
What are the key applications of Mobile Blood Collection Service?
Key applications covered include Cancer, Infectious Disease, Vaccine Clinical Trials and Others.
Which companies are profiled in the Mobile Blood Collection Service market report?
Key players profiled include NeoGenomics Laboratories, Viracor-lBT Laboratories, Angel's on Wheels Mobile Phlebotomy, Sonora Quest Laboratories, TravaLab LLC, Ultimate Wellness Providers, Mobile Phlebotomy Services and Pinnacle Mobile Phlebotomy, among 10 companies covered in total.
What geographies does the Mobile Blood Collection Service market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Mobile Blood Collection Service?
Rising prevalence of cancer and infectious diseases, increasing demand for home point-of-care testing among the masses, and development of innovative home care technologies are the key factors driving the growth of mobile blood collection services market revenue.
Who should buy the Mobile Blood Collection Service market report?
The report is intended for manufacturers and solution providers, distributors and end users in Cancer, Infectious Disease and Vaccine Clinical Trials, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Mobile Blood Collection Service market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

All data sources are cited within the report. View our full research methodology →
Select a license
from 3.500,00 US$
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.